Supplemental Material for: Retrospective analysis of real-world elacestrant use in two large Austrian cancer centers
figshare admin karger(Karger Publishers (Switzerland)), Maximilian Marhold(Medical University of Vienna), Kerstin Wimmer(Comprehensive Cancer Center Vienna), Rupert Bartsch(Universitätszahnklinik Wien), Ruth Exner(Comprehensive Cancer Center Vienna), Constantin Mannsbart, Stefan Konrad, Simon Udovica, Kathrin Strasser-Weippl, Lisa Vesenmayer, Christian F. Singer, Leonhard Müllauer(Hochschule Campus Wien), Katharina Kantner, Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna)
Cited by 0
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303